List of Excipients in API methotrexate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing methotrexate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Accord Healthcare Inc | METHOTREXATE | methotrexate | 16729-516 | SODIUM HYDROXIDE | |
| Rebel Distributors Corp | METHOTREXATE | methotrexate | 42254-110 | LACTOSE | |
| Rebel Distributors Corp | METHOTREXATE | methotrexate | 42254-110 | MAGNESIUM STEARATE | |
| Rebel Distributors Corp | METHOTREXATE | methotrexate | 42254-110 | STARCH, CORN | |
| A-S Medication Solutions | METHOTREXATE | methotrexate | 50090-0294 | LACTOSE MONOHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing methotrexate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 | HYDROCHLORIC ACID |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 | SODIUM HYDROXIDE |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 | HYDROCHLORIC ACID |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 | SODIUM CHLORIDE |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 | SODIUM HYDROXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for methotrexate
Excipient focus: ANHYDROUS LACTOSE
methotrexate drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| Accord Healthcare Inc | methotrexate | 16729-486 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZYL ALCOHOL
methotrexate drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | methotrexate | 61703-350 |
| Fresenius Kabi USA LLC | methotrexate sodium | 63323-123 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
methotrexate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| Alembic Pharmaceuticals Limited | methotrexate | 46708-730 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
methotrexate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
methotrexate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
methotrexate drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLPARABEN
methotrexate drug variants containing ETHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing ETHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
methotrexate drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
methotrexate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Mylan Institutional Inc | methotrexate | 51079-670 |
| Golden State Medical Supply Inc | methotrexate | 51407-121 |
| Bryant Ranch Prepack | methotrexate | 71335-1118 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
methotrexate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
methotrexate drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
methotrexate drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| Accord Healthcare Inc | methotrexate | 16729-277 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3678 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| Accord Healthcare Inc | methotrexate | 16729-486 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL METHYLCELLULOSE
methotrexate drug variants containing HYDROXYPROPYL METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | methotrexate | 50090-5457 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing HYDROXYPROPYL METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
methotrexate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | methotrexate | 50090-2345 |
| Bryant Ranch Prepack | methotrexate | 71335-0782 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
methotrexate drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | methotrexate sodium | 21695-111 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
methotrexate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
methotrexate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| REMEDYREPACK INC | methotrexate | 70518-3777 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
methotrexate drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | methotrexate | 42254-110 |
| Dispensing Solutions Inc | methotrexate | 66336-338 |
| GenPak Solutions LLC | methotrexate sodium | 75840-111 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
methotrexate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| AvKARE | methotrexate | 42291-505 |
| Alembic Pharmaceuticals Limited | methotrexate | 46708-730 |
| Alvogen Inc | methotrexate | 47781-482 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
methotrexate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| Accord Healthcare Inc | methotrexate | 16729-486 |
| Rebel Distributors Corp | methotrexate | 42254-110 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3678 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN SODIUM
methotrexate drug variants containing METHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing METHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
methotrexate drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Mylan Institutional Inc | methotrexate | 51079-670 |
| Golden State Medical Supply Inc | methotrexate | 51407-121 |
| Bryant Ranch Prepack | methotrexate | 71335-1118 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
methotrexate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| A-S Medication Solutions | methotrexate | 50090-2345 |
| A-S Medication Solutions | methotrexate | 50090-5457 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
methotrexate drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
methotrexate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
methotrexate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| A-S Medication Solutions | methotrexate | 50090-2345 |
| A-S Medication Solutions | methotrexate | 50090-5457 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN SODIUM
methotrexate drug variants containing PROPYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing PROPYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
methotrexate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Mylan Institutional Inc | methotrexate | 51079-670 |
| Golden State Medical Supply Inc | methotrexate | 51407-121 |
| Bryant Ranch Prepack | methotrexate | 71335-1118 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CARBONATE MONOHYDRATE
methotrexate drug variants containing SODIUM CARBONATE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Rebel Distributors Corp | methotrexate sodium | 21695-111 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SODIUM CARBONATE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3678 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
methotrexate drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3678 |
| Accord Healthcare Inc | methotrexate | 16729-277 |
| Antares Pharma Inc | methotrexate | 54436-075 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
methotrexate drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
methotrexate drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3678 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| Accord Healthcare Inc | methotrexate | 16729-486 |
| Rebel Distributors Corp | methotrexate | 42254-110 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
methotrexate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Mylan Institutional Inc | methotrexate | 51079-670 |
| Golden State Medical Supply Inc | methotrexate | 51407-121 |
| Bryant Ranch Prepack | methotrexate | 71335-1118 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
methotrexate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Mylan Institutional Inc | methotrexate | 51079-670 |
| Golden State Medical Supply Inc | methotrexate | 51407-121 |
| Bryant Ranch Prepack | methotrexate | 71335-1118 |
| Hikma Pharmaceuticals USA Inc | methotrexate sodium | 0054-4550 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
methotrexate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| Accord Healthcare Inc | methotrexate | 16729-486 |
| Rebel Distributors Corp | methotrexate | 42254-110 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3678 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
methotrexate drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
methotrexate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| A-S Medication Solutions | methotrexate | 50090-2345 |
| A-S Medication Solutions | methotrexate | 50090-5457 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
methotrexate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
methotrexate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3678 |
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| Antares Pharma Inc | methotrexate | 54436-075 |
| Medexus Pharma Inc | methotrexate | 59137-505 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9367 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9519 |
| Hikma Pharmaceuticals USA Inc | methotrexate | 0143-9830 |
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
